Beijing Jingke Ruida Technology Co., Ltd

We cordially invite you to attend

BCEIA 2021

Booth Number: 2329

Scan the QR code on WeChat

Enter the audience registration interface

The 19th Beijing Analysis and Testing Academic Report Conference and Exhibition (BCEIA 2021) will be grandly opened at the China International Exhibition Center (Tianzhu New Hall) in Beijing from September 27th to 29th, 2021. The conference will continue to uphold the vision of "analyzing science to create the future" and hold academic presentations, forums, and instrument exhibitions around the theme of "life ecology - facing a green future". Jiang Guibin, an academician of the CAS Member and director of the State Key Laboratory of Environmental Chemistry and Ecotoxicology, served as the chairman of the conference, and Tan Weihong, an academician of the CAS Member and director of the Institute of Basic Medicine and Cancer of the Chinese Academy of Sciences, served as the chairman of the academic committee.

Compared to previous editions, BCEIA 2021 has added many highlights. Firstly, we have made great efforts to create the "Summit Forum on the Development of Diagnosis and Treatment Technology under the New Pandemic". In addition to its interdisciplinary and cross disciplinary characteristics, the forum also has a wide range of communication content. Around several major directions such as diagnosis, omics, models, vaccines, and treatment, we have invited industry experts to share the latest research results. The distribution of experts in the report is very representative, covering scientific researchers in various fields such as virus structure research, transmission path analysis, detection and diagnosis, experimental animal models, vaccine development, Chinese medicine treatment, and anti epidemic first-line hospitals. At the same time, international scholars also participate in online exchanges, such as Academician Tan Weihong, who has an important influence in the field of international bioanalytic chemistry, Academician Wang Chen, Vice President of the Chinese Medical Association/Professor Cao Bin, Vice President of the China-Japan Friendship Hospital, Researcher Tan Wenjie, Director of the Viral Disease Emergency Technology Center of the Chinese Center for Disease Control and Prevention, Researcher Guo Tiannan, who discovered important biomarkers of new * severe patients, and Vice President of the Beijing Future Gene Diagnosis Center for Innovation, Peking University Director Professor Huang Yanyi, "SARS" in 2003 and the new*Director Wang Yajie of the Laboratory Department of Beijing Ditan Hospital, the main hospital for infectious diseases in the Beijing area, and others. The forum will provide industry experts, scholars, business managers, medical researchers, and clinical laboratory technicians with ample opportunities for discussion and exchange through sharing experiences and technologies, and jointly respond to the epidemicFor peoplehealthyThe threat posed by Kang.